Clough Capital Partners L P Galapagos Nv Transaction History

Clough Capital Partners L P

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 17, 2020	SELL	$122.47 - $213.56 $2.09 Million - $3.64 Million	-17,066 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$185.52 - $231.25 $794,025 - $989,750	-4,280 Reduced 20.05%	17,066 $3.37 Million
Q1 2020 May 15, 2020	BUY	$143.0 - $274.03 $326,040 - $624,788	2,280 Added 11.96%	21,346 $4.18 Million
Q4 2019 Feb 14, 2020	SELL	$146.12 - $215.82 $1.86 Million - $2.75 Million	-12,757 Reduced 40.09%	19,066 $3.94 Million
Q3 2019 Nov 14, 2019	SELL	$130.44 - $187.64 $4.19 Million - $6.03 Million	-32,150 Reduced 50.26%	31,823 $4.86 Million
Q2 2019 Aug 14, 2019	BUY	$111.45 - $128.93 $5.7 Million - $6.59 Million	51,120 Added 397.73%	63,973 $8.25 Million
Q1 2019 May 15, 2019	SELL	$89.61 - $117.78 $1.19 Million - $1.56 Million	-13,250 Reduced 50.76%	12,853 $1.51 Million
Q4 2018 Feb 14, 2019	BUY	$87.81 - $110.65 $487,345 - $614,107	5,550 Added 27.0%	26,103 $2.4 Million
Q3 2018 Nov 14, 2018	SELL	$90.63 - $120.22 $2.78 Million - $3.69 Million	-30,700 Reduced 59.9%	20,553 $2.31 Million
Q2 2018 Aug 14, 2018	BUY	$88.4 - $105.34 $114,920 - $136,942	1,300 Added 2.6%	51,253 $4.73 Million
Q1 2018 May 15, 2018	SELL	$94.51 - $120.23 $1.56 Million - $1.98 Million	-16,500 Reduced 24.83%	49,953 $4.98 Million
Q4 2017 Feb 14, 2018	SELL	$84.48 - $104.02 $506,880 - $624,120	-6,000 Reduced 8.28%	66,453 $6.23 Million
Q3 2017 Nov 14, 2017	BUY	$73.17 - $103.47 $5.3 Million - $7.5 Million	72,453	72,453 $7.37 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

Stay updated on Clough Capital Partners L P with notifications on news.